Nidek v. Visx
This article was originally published in The Gray Sheet
Nidek is now permitted to recommence action in its antitrust allegations against Visx following U.S. District Court Judge Charles Breyer's decision to lift a stay currently in place on the case. Judge Breyer's decision follows a Dec. 6 ruling by International Trade Commission Administrative Law Judge Debra Morriss that Nidek does not infringe two Visx LASIK patents covering the apparatus and method for performing the ophthalmic surgical procedure (1"The Gray Sheet" Dec. 13, p. 15)
You may also be interested in...
A recent ruling by the International Trade Commission weakens, at least temporarily, the patent position of Visx and co-licensor Summit Technology in the rapidly growing laser-assisted in situ keratomileusis (LASIK) market, and creates an opening for a formidable competitor, Bausch & Lomb, whose Technolas LASIK device awaits FDA approval.
Device Week, 4 December 2020 – MedWatch Question About Third-Party Servicers Slides Under Industry's Radar
On this week’s podcast: A change made by the US FDA to its MedWatch program that asks adverse event reporters whether a third party serviced a malfunctioning medical device went unnoticed by many in industry for nearly a year. We explain why, and tell how the servicer question will be helpful for manufacturers and the agency.
The series D financing will support the expansion of Everlywell’s consumer lab testing and digital health businesses.